MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 126 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,093,000 | -30.7% | 11,136 | -40.2% | 0.00% | 0.0% |
| Q4 2021 | $1,578,000 | +6.2% | 18,616 | -0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,486,000 | +119.2% | 18,624 | +167.4% | 0.00% | – |
| Q2 2021 | $678,000 | -21.3% | 6,965 | -5.3% | 0.00% | – |
| Q1 2021 | $861,000 | +140.5% | 7,357 | +128.6% | 0.00% | – |
| Q4 2020 | $358,000 | +33.6% | 3,218 | +42.5% | 0.00% | – |
| Q3 2020 | $268,000 | +13.1% | 2,259 | +8.0% | 0.00% | – |
| Q2 2020 | $237,000 | -75.7% | 2,091 | -54.1% | 0.00% | -100.0% |
| Q3 2018 | $976,000 | -68.8% | 4,560 | -59.2% | 0.00% | -66.7% |
| Q2 2018 | $3,129,000 | +85.8% | 11,187 | -22.4% | 0.00% | +50.0% |
| Q1 2018 | $1,684,000 | +20.1% | 14,423 | -5.6% | 0.00% | +100.0% |
| Q4 2017 | $1,402,000 | – | 15,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |